The European Neuroendocrine Tumor Society (ENETS) guidelines advocate a right hemicolectomy (RHC) only in patients with appendiceal neuroendocrine neoplasms (aNENs) at risk for N+(node positive). The risk is defined using site, size, and grading of tumor as well as mesoappendiceal or lymphovascular invasion.
Ricci, C., Ingaldi, C., Alberici, L., Brighi, N., Santini, D., Mosconi, C., et al. (2019). Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis. ENDOCRINE, 66(3), 460-466 [10.1007/s12020-019-01984-z].
Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis
Ricci, Claudio;Ingaldi, Carlo;Alberici, Laura;Brighi, Nicole;Mosconi, Cristina;Ambrosini, Valentina;Campana, Davide;Minni, Francesco;Casadei, Riccardo
2019
Abstract
The European Neuroendocrine Tumor Society (ENETS) guidelines advocate a right hemicolectomy (RHC) only in patients with appendiceal neuroendocrine neoplasms (aNENs) at risk for N+(node positive). The risk is defined using site, size, and grading of tumor as well as mesoappendiceal or lymphovascular invasion.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
